US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Incyte

127.81

+0.59000.46%

Post-market: 127.810.00000.00%19:30 EDT

Volume:1.37M

Turnover:175.38M

Market Cap:25.91B

PE:16.28

High:129.92

Open:126.45

Low:125.60

Close:127.22

52wk High:132.60

52wk Low:81.09

Shares:202.70M

Float Shares:169.82M

Volume Ratio:1.00

T/O Rate:0.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):7.85

EPS(LYR):6.41

ROE:30.67%

ROA:16.83%

PB:4.08

PE(LYR):19.94

Loading ...

Overview Company News Filings

Incyte settles CMS Opzelura Medicaid rebate dispute, drops lawsuit

Incyte : Bmo Raises to Market Perform From Underperform; Raises Target Price to $94 From $75

THOMSON REUTERS

Incyte Raised to Market Perform From Underperform by BMO Capital

BMO Capital Upgrades Incyte to Market Perform From Underperform, Adjusts PT to $94 From $75

MT Newswires Live

Incyte upgraded to Market Perform from Underperform at BMO Capital

Evan Seigerman Raises Incyte Price Target to $94 but Maintains Hold on Balanced View of Strategic Progress and Post-2029 LOE Risks

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Incyte Japan announces approval of Minjuvi combination for DLBCL

Incyte Japan wins approval for Minjuvi-lenalidomide in relapsed or refractory DLBCL

Incyte Japan Announces Approval of Minjuvi® (Tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl)

THOMSON REUTERS

Incyte : Jefferies Raises Target Price to $100 From $94

THOMSON REUTERS

Incyte (INCY) Stock Could Be 8.1% Undervalued After FDA Priority Review And Trial Results

Simply Wall St.

Incyte Corp. Stock Slips 6.0%, Underperforms Peers

Movement Alert｜Incyte Declines 5.37% in Regular Trading, Trading at $104.11

Salveen Richter Reiterates Hold on Incyte as Mid‑Stage INCA033989 Data Align with Expectations Amid Rising Myelofibrosis Competition

Incyte: Buy Rating Reaffirmed on Promising INCA033989 Data and Risk-Reward, $124 Price Target Unchanged

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)

Matt Phipps Reiterates Hold on Incyte as Encouraging INCA033989 Data Offset by Efficacy Moderation and Phase III Execution Risks

Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial

MT Newswires Live

Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/INCY/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"Incyte","latestPrice":127.81,"timestamp":1787342400000,"preClose":127.22,"halted":0,"volume":1367411,"hourTrading":{"tag":"盘后","latestPrice":127.81,"preClose":127.81,"latestTime":"19:30 EDT","volume":49842,"amount":6374351.062,"timestamp":1787355003693,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.004637635591888095,"floatShares":169819727,"shares":202697746,"eps":7.85,"marketStatus":"Not Yet Opened","change":0.59,"latestTime":"08-21 16:00:00 EDT","open":126.45,"high":129.92,"low":125.6,"amount":175376094.48332,"amplitude":0.033957,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.85,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":127.22,"preHourTrading":{"tag":"盘前","latestPrice":126.74,"preClose":127.22,"latestTime":"09:29 EDT","volume":1779,"amount":225832.07733,"timestamp":1787318999996,"change":-0.48,"changeRate":-0.003773,"amplitude":0.02704},"postHourTrading":{"tag":"盘后","latestPrice":127.81,"preClose":127.81,"latestTime":"19:30 EDT","volume":49842,"amount":6374351.062,"timestamp":1787355003693,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.003363596443399,"impliedVol":0.3379,"impliedVolPercentile":0.259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":169819727,"roa":"16.83%","roe":"30.67%","lyrEps":6.41,"volumeRatio":1.003363596443399,"shares":202697746,"dividePrice":0,"high":129.92,"amplitude":0.033957,"preClose":127.22,"low":125.6,"week52Low":81.09,"pbRate":"4.08","psRate":"4.45","week52High":132.6,"institutionHeld":0.9185,"latestPrice":127.81,"eps":7.85,"divideRate":0,"volume":1367411,"delay":0,"ttmEps":7.85,"open":126.45,"prevYearClose":98.77,"prevWeekClose":120.16,"prevMonthClose":119.52,"prevQuarterClose":113.36,"fiveDayClose":120.16,"twentyDayClose":117.67,"sixtyDayClose":97.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"INCY","fiscalQuarterEnding":"2026/06","expectedEps":1.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":2.8},{"market":"US","date":"2026-04-28","symbol":"INCY","fiscalQuarterEnding":"2026/03","expectedEps":1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777348800000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2026-02-10","symbol":"INCY","fiscalQuarterEnding":"2025/12","expectedEps":1.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2025-10-28","symbol":"INCY","fiscalQuarterEnding":"2025/09","expectedEps":1.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":2.03},{"market":"US","date":"2025-07-29","symbol":"INCY","fiscalQuarterEnding":"2025/06","expectedEps":1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"pre","actualEps":1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2069,"buy":0.2414,"hold":0.5517,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2414,"analysts":29,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2026-08-21","current":16.281529,"percent":0.124796,"low":12.870654,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"high":648.145308,"avg":97.761667,"sd":164.540207,"marketCap":25787207246},"quantilePoints":[{"date":"2021-08-27","current":49.499207,"twenty":-126.920152,"median":-53.75838,"eighty":133.981527,"marketCap":16712813157},{"date":"2021-09-03","current":49.767371,"twenty":-126.920152,"median":-53.75838,"eighty":132.851508,"marketCap":16803355618},{"date":"2021-09-10","current":46.516696,"twenty":-126.920152,"median":-53.75838,"eighty":131.356968,"marketCap":15705804331},{"date":"2021-09-17","current":49.701965,"twenty":-126.920152,"median":-53.75838,"eighty":73.50992,"marketCap":16781272091},{"date":"2021-09-24","current":45.130091,"twenty":-126.920152,"median":-53.75838,"eighty":72.160274,"marketCap":15237633561},{"date":"2021-10-01","current":44.613384,"twenty":-126.920152,"median":-53.75838,"eighty":71.599051,"marketCap":15063173698},{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-25","current":349.904367,"twenty":-53.209696,"median":27.168166,"eighty":48.304069,"marketCap":11412130919},{"date":"2025-05-02","current":564.51072,"twenty":-53.209696,"median":27.168166,"eighty":48.393956,"marketCap":12007143006},{"date":"2025-05-09","current":543.579321,"twenty":-52.564683,"median":27.496923,"eighty":48.460691,"marketCap":11561932157},{"date":"2025-05-16","current":571.154163,"twenty":15.632391,"median":27.625789,"eighty":48.737881,"marketCap":12148449057},{"date":"2025-05-23","current":587.080228,"twenty":15.726225,"median":27.883789,"eighty":49.007354,"marketCap":12487196442},{"date":"2025-05-30","current":601.004158,"twenty":15.826258,"median":28.029696,"eighty":49.252879,"marketCap":12783358441},{"date":"2025-06-06","current":611.924888,"twenty":15.885314,"median":28.339221,"eighty":49.434802,"marketCap":13015642362},{"date":"2025-06-13","current":629.944092,"twenty":15.934986,"median":28.478966,"eighty":49.660105,"marketCap":13398910831},{"date":"2025-06-20","current":621.298514,"twenty":15.990815,"median":28.671445,"eighty":49.822312,"marketCap":13215019394},{"date":"2025-06-27","current":644.414059,"twenty":16.096118,"median":28.856014,"eighty":50.382952,"marketCap":13706687026},{"date":"2025-07-03","current":622.936624,"twenty":16.116941,"median":28.993122,"eighty":50.591002,"marketCap":13249861982},{"date":"2025-07-11","current":640.136773,"twenty":16.200713,"median":29.581278,"eighty":51.047771,"marketCap":13615709157},{"date":"2025-07-18","current":627.395921,"twenty":16.252966,"median":30.035802,"eighty":51.822721,"marketCap":13344711249},{"date":"2025-07-25","current":641.501864,"twenty":16.33326,"median":30.242404,"eighty":52.761862,"marketCap":13644744647},{"date":"2025-08-01","current":16.792668,"twenty":16.378635,"median":30.24819,"eighty":52.992543,"marketCap":14624230499},{"date":"2025-08-08","current":17.534873,"twenty":16.546711,"median":30.24819,"eighty":52.992543,"marketCap":15270594539},{"date":"2025-08-15","current":19.319752,"twenty":16.607924,"median":30.24819,"eighty":52.992543,"marketCap":16824992653},{"date":"2025-08-22","current":19.402718,"twenty":16.798469,"median":30.24819,"eighty":52.992543,"marketCap":16897244826},{"date":"2025-08-29","current":18.768144,"twenty":16.870655,"median":30.24819,"eighty":52.992543,"marketCap":16344613336},{"date":"2025-09-05","current":19.158306,"twenty":16.99751,"median":30.268023,"eighty":53.052464,"marketCap":16684393828},{"date":"2025-09-12","current":19.321995,"twenty":17.085907,"median":30.24819,"eighty":52.992543,"marketCap":16826945414},{"date":"2025-09-19","current":19.283875,"twenty":17.161262,"median":30.24819,"eighty":52.992543,"marketCap":16793748470},{"date":"2025-09-26","current":18.310712,"twenty":17.193493,"median":30.24819,"eighty":52.992543,"marketCap":15946250000},{"date":"2025-10-03","current":19.34666,"twenty":17.274387,"median":30.24819,"eighty":52.992543,"marketCap":16848425790},{"date":"2025-10-10","current":19.003586,"twenty":17.291711,"median":30.24819,"eighty":52.992543,"marketCap":16549653288},{"date":"2025-10-17","current":19.577618,"twenty":17.328736,"median":30.24819,"eighty":52.992543,"marketCap":17049560219},{"date":"2025-10-24","current":20.02608,"twenty":17.356711,"median":30.24819,"eighty":52.992543,"marketCap":17440112509},{"date":"2025-10-31","current":15.211911,"twenty":17.362586,"median":30.24819,"eighty":52.992543,"marketCap":18080618265},{"date":"2025-11-07","current":17.376278,"twenty":17.372241,"median":30.24819,"eighty":52.992543,"marketCap":20653148355},{"date":"2025-11-14","current":17.410964,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":20694376123},{"date":"2025-11-21","current":16.80808,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":19977798257},{"date":"2025-11-28","current":17.254049,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":20507869555},{"date":"2025-12-05","current":16.593354,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19722578743},{"date":"2025-12-12","current":15.873197,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":18866611758},{"date":"2025-12-19","current":16.073057,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19104162228},{"date":"2025-12-26","current":16.590051,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19718652289},{"date":"2026-01-02","current":16.314211,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19390793375},{"date":"2026-01-09","current":17.495203,"twenty":17.426189,"median":30.24819,"eighty":52.992543,"marketCap":20794500701},{"date":"2026-01-16","current":17.382885,"twenty":17.442549,"median":30.24819,"eighty":52.992543,"marketCap":20661001263},{"date":"2026-01-23","current":17.353153,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20625663177},{"date":"2026-01-30","current":16.695762,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":19844298819},{"date":"2026-02-06","current":16.973254,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20174120960},{"date":"2026-02-13","current":15.583655,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20050709464},{"date":"2026-02-20","current":15.735238,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20245743660},{"date":"2026-02-27","current":15.481568,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19919359903},{"date":"2026-03-06","current":15.054661,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19370079922},{"date":"2026-03-13","current":14.234876,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18315303146},{"date":"2026-03-20","current":14.377178,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18498396473},{"date":"2026-03-27","current":14.270452,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18361076478},{"date":"2026-04-02","current":14.585992,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18767066029},{"date":"2026-04-10","current":14.997431,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19296444562},{"date":"2026-04-17","current":14.743762,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18970060805},{"date":"2026-04-24","current":14.766963,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18999912978},{"date":"2026-05-01","current":13.293443,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19033245906},{"date":"2026-05-08","current":13.642279,"twenty":17.433127,"median":30.118443,"eighty":52.992543,"marketCap":19532701294},{"date":"2026-05-15","current":13.622744,"twenty":17.411313,"median":29.746559,"eighty":52.992543,"marketCap":19504731792},{"date":"2026-05-22","current":13.592047,"twenty":17.387328,"median":29.09859,"eighty":52.992543,"marketCap":19460779718},{"date":"2026-05-29","current":13.604605,"twenty":17.36462,"median":28.916658,"eighty":53.052464,"marketCap":19478760112},{"date":"2026-06-05","current":14.126463,"twenty":17.348937,"median":28.776913,"eighty":52.992543,"marketCap":20225945372},{"date":"2026-06-12","current":15.045995,"twenty":17.325325,"median":28.50797,"eighty":52.992543,"marketCap":21542509773},{"date":"2026-06-18","current":13.812511,"twenty":17.289424,"median":28.436682,"eighty":52.992543,"marketCap":19776435523},{"date":"2026-06-26","current":15.004135,"twenty":17.272525,"median":28.112465,"eighty":53.052464,"marketCap":21482575127},{"date":"2026-07-02","current":15.880411,"twenty":17.240692,"median":27.997224,"eighty":53.052464,"marketCap":22737207060},{"date":"2026-07-10","current":16.537618,"twenty":17.19048,"median":27.743327,"eighty":53.052464,"marketCap":23678181010},{"date":"2026-07-17","current":16.276689,"twenty":17.163644,"median":27.552445,"eighty":53.052464,"marketCap":23304588380},{"date":"2026-07-24","current":16.28227,"twenty":17.105678,"median":27.323117,"eighty":53.052464,"marketCap":23312579666},{"date":"2026-07-31","current":15.46146,"twenty":17.048056,"median":27.019412,"eighty":53.112386,"marketCap":24929795780},{"date":"2026-08-07","current":14.881923,"twenty":16.977387,"median":26.862395,"eighty":53.112386,"marketCap":23995359171},{"date":"2026-08-14","current":15.150949,"twenty":16.947387,"median":26.172344,"eighty":53.112386,"marketCap":24429132347},{"date":"2026-08-21","current":15.993227,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"marketCap":25787207246}],"updateTime":1787505847225},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645702994","title":"Incyte settles CMS Opzelura Medicaid rebate dispute, drops lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2645702994","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645702994?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:01","pubTimestamp":1782126088,"startTime":"0","endTime":"0","summary":"Incyte reached a settlement with CMS to resolve litigation over Medicaid rebate rules applied to Opzelura.CMS will not treat Opzelura as a line extension of Jakafi under the line extension regulation.Plans a one-time, non-cash benefit of about USD 246 million in Q2 ended June 30, 2026 from reversing accruals.Stops accruing for the line extension risk for Opzelura; expects improved gross-to-net going forward.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information containe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL926kGq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","BK4588","BK4585","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645026157","title":"Incyte : Bmo Raises to Market Perform From Underperform; Raises Target Price to $94 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2645026157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645026157?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:39","pubTimestamp":1782124782,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42T087:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","INCY","BK4532","BK4139","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645023389","title":"Incyte Raised to Market Perform From Underperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2645023389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645023389?lang=en_us&edition=fundamental","pubTime":"2026-06-22 17:32","pubTimestamp":1782120720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 05:32 ET (09:32 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMO","INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645028439","title":"BMO Capital Upgrades Incyte to Market Perform From Underperform, Adjusts PT to $94 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2645028439","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645028439?lang=en_us&edition=fundamental","pubTime":"2026-06-22 17:18","pubTimestamp":1782119933,"startTime":"0","endTime":"0","summary":"Incyte (INCY) has an average rating of overweight and mean price target of $111.95, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMO","INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645040551","title":"Incyte upgraded to Market Perform from Underperform at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2645040551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645040551?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:35","pubTimestamp":1782117345,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Evan Seigerman upgraded Incyte (INCY) to Market Perform from Underperform with a price target of $94, up from $75. The company ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-upgraded-to-market-perform-from-underperform-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-upgraded-to-market-perform-from-underperform-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","BMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645403200","title":"Evan Seigerman Raises Incyte Price Target to $94 but Maintains Hold on Balanced View of Strategic Progress and Post-2029 LOE Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2645403200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645403200?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:25","pubTimestamp":1782116721,"startTime":"0","endTime":"0","summary":"In a report released today, Evan Seigerman from BMO Capital upgraded Incyte to a Hold, with a price target of $94.00. Evan Seigerman has given his ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/evan-seigerman-raises-incyte-price-target-to-94-but-maintains-hold-on-balanced-view-of-strategic-progress-and-post-2029-loe-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/evan-seigerman-raises-incyte-price-target-to-94-but-maintains-hold-on-balanced-view-of-strategic-progress-and-post-2029-loe-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","PRGS","POST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645042865","title":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon","url":"https://stock-news.laohu8.com/highlight/detail?id=2645042865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645042865?lang=en_us&edition=fundamental","pubTime":"2026-06-22 15:47","pubTimestamp":1782114448,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, VisteonJune 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U0H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AALG","INTC","ABVX","FPS","KMX","INCY","KLAC","LRCX","MUU","ALT","KR","HCA","FANG","ENPH","MRK","LQDA","AGMB","BWIN","MRNX","AMAT","CNXU","MULL","VC","MTDR","BWXT","MRNY","LGN","LINT","ARMK","DFTX","LRCU","DAR","AMRZ","BILL","FMC","GLW","KLAG","APGE","BYD","DCH","FTH","INTW","MU","CHRD","MRNA","ALGM","DAL","NBIX","AAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644054815","title":"Incyte Japan announces approval of Minjuvi combination for DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2644054815","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644054815?lang=en_us&edition=fundamental","pubTime":"2026-06-19 19:10","pubTimestamp":1781867435,"startTime":"0","endTime":"0","summary":"Incyte (INCY) Biosciences Japan G.K. announced that Japan’s Ministry of Health, Labour and Welfare has approved Minjuvi in combination with lenalid...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-japan-announces-approval-of-minjuvi-combination-for-dlbcl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-japan-announces-approval-of-minjuvi-combination-for-dlbcl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","INCY","BK4139","BK4585","BK4550","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644053486","title":"Incyte Japan wins approval for Minjuvi-lenalidomide in relapsed or refractory DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2644053486","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644053486?lang=en_us&edition=fundamental","pubTime":"2026-06-19 14:00","pubTimestamp":1781848841,"startTime":"0","endTime":"0","summary":"Incyte won Japan MHLW clearance for Minjuvi  with lenalidomide in adults with relapsed or refractory DLBCL.Decision targets patients ineligible for autologous stem cell transplant.L-MIND showed 58.8% ORR, including 41.3% complete responses; J-MIND showed 71.4% ORR, including 45.2% complete responses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire  on June 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nNDL5MYMqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","BK4588","BK4585","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644053944","title":"Incyte Japan Announces Approval of Minjuvi® (Tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644053944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644053944?lang=en_us&edition=fundamental","pubTime":"2026-06-19 14:00","pubTimestamp":1781848801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nTUA4CRJXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","BK4588","INCY","BK4585","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644744434","title":"Incyte : Jefferies Raises Target Price to $100 From $94","url":"https://stock-news.laohu8.com/highlight/detail?id=2644744434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644744434?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:21","pubTimestamp":1781706102,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","INCY","BK4139","BK4585","BK4550","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644990748","title":"Incyte (INCY) Stock Could Be 8.1% Undervalued After FDA Priority Review And Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2644990748","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644990748?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:41","pubTimestamp":1781692884,"startTime":"0","endTime":"0","summary":"Recent interest in Incyte (INCY) stock is closely tied to fresh clinical and regulatory milestones, including pivotal data for zilurgisertib in fibrodysplasia ossificans progressiva and Phase 3 results for tafasitamab plus lenalidomide with R-CHOP.\nSee our latest analysis for Incyte.\nIncyte stock has cooled slightly in the very short term, with a 1-day share price return of 2.19% and a 7-day share price return of 5.35%. However, the 1-year total shareholder return of 46.11% and 3-year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-81-undervalued-after-fda-priority","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-stock-could-be-81-undervalued-after-fda-priority","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4585","BK4550","INCY","BK4139","LABU","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643786820","title":"Incyte Corp. Stock Slips 6.0%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2643786820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643786820?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:34","pubTimestamp":1781555640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Incyte Corp. slid 6.0% to $101.98 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.7% to 7,554.29 and the Dow Jones Industrial Average rising 0.9% to 51,671.03.The stock's fall snapped a four-day winning streak.Incyte Corp. closed 9.2% below its 52-week high of $112.29, which the company reached on January 7th.The stock underperformed when compared to some of its peers, as Alnylam Pharmaceuticals Inc. rose 1.8% to $287.80, Bio-Techne Corp. rose 4.0% to $56.17, and BioMarin Pharmaceutical Inc. fell 0.54% to $55.65.Trading volume totaled 2.8 million, compared to the 50-day average of 1.5 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168018671","title":"Movement Alert｜Incyte Declines 5.37% in Regular Trading, Trading at $104.11","url":"https://stock-news.laohu8.com/highlight/detail?id=1168018671","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168018671?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:04","pubTimestamp":1781535878,"startTime":"0","endTime":"0","summary":"On June 15, Incyte declined 5.37% in regular trading, trading at $104.11/share, with Turnover of $64.25 million.Within the Biotechnology sector where Incyte belongs, the overall sector performance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203209","title":"Salveen Richter Reiterates Hold on Incyte as Mid‑Stage INCA033989 Data Align with Expectations Amid Rising Myelofibrosis Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:45","pubTimestamp":1781531134,"startTime":"0","endTime":"0","summary":"Incyte, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Salveen Richter from Goldman Sachs maintained a Hold r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/salveen-richter-reiterates-hold-on-incyte-as-midstage-inca033989-data-align-with-expectations-amid-rising-myelofibrosis-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/salveen-richter-reiterates-hold-on-incyte-as-midstage-inca033989-data-align-with-expectations-amid-rising-myelofibrosis-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","IE0034235188.USD","IE0002270589.USD","LU1791807156.HKD","BK4532","BK4139","LU2750360997.AUD","LU0061475181.USD","LU1868837300.USD","GSX","LU0251131958.USD","LU0742534661.SGD","LU0868494617.USD","LU0868494708.USD","LU1804176565.USD","BK4516","LU2471134796.USD","LU1868836914.USD","BK4504","LU2471134523.USD","LU1868836591.USD","LU0096364046.USD","LU1894683264.USD","LU2237438978.USD","LU0106831901.USD","BK4581","LU2237443978.SGD","BK4550","LU1894683348.USD","IE0004091025.USD","LU2265009873.SGD","LU2471134952.CNY","LU2237443622.USD","BK4533","LU2237443895.HKD","LU1668664300.SGD","IE00BFXG1179.USD","LU0942090050.USD","IE00B19Z3581.USD","LU0048573561.USD","IE00B19Z3B42.SGD","XBI","LU2471134879.HKD","LU2237443549.SGD","LU0345770308.USD","LU0345770993.USD","XLV","LU1868836757.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208923","title":"Incyte: Buy Rating Reaffirmed on Promising INCA033989 Data and Risk-Reward, $124 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208923?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:35","pubTimestamp":1781523322,"startTime":"0","endTime":"0","summary":"Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Incyte. The associated price target remains the same with $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incyte-buy-rating-reaffirmed-on-promising-inca033989-data-and-risk-reward-124-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incyte-buy-rating-reaffirmed-on-promising-inca033989-data-and-risk-reward-124-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643127086","title":"Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643127086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643127086?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:50","pubTimestamp":1781520645,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-incyte-incy-intellia-therapeutics-ntla-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-incyte-incy-intellia-therapeutics-ntla-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053671581.USD","BK4588","NTLA","XLV","BK4581","XBI","LABU","LU1861558580.USD","INCY","BK4556","BK4137","LU1861559042.SGD","LU0029874061.USD","BK4550","HALO","BK4139","BK4535","HCSG","BK4532","LU0128526141.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643274777","title":"Matt Phipps Reiterates Hold on Incyte as Encouraging INCA033989 Data Offset by Efficacy Moderation and Phase III Execution Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2643274777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643274777?lang=en_us&edition=fundamental","pubTime":"2026-06-15 17:48","pubTimestamp":1781516930,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their neutral stance on INCY stock, giving a Hold rating on June 9. Matt Phipps has given his Hold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-reiterates-hold-on-incyte-as-encouraging-inca033989-data-offset-by-efficacy-moderation-and-phase-iii-execution-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-reiterates-hold-on-incyte-as-encouraging-inca033989-data-offset-by-efficacy-moderation-and-phase-iii-execution-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY","BK4532","BK4588","BK4550","III","BK4585","BK4139","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643275959","title":"Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643275959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643275959?lang=en_us&edition=fundamental","pubTime":"2026-06-15 16:00","pubTimestamp":1781510444,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals  and Incyte  said Sunday their threapeutic candidate for fibrodysplasia ossificans progressiva, zilurgisertib, demonstrated positive results during a phase 2 study.The product showed meaningful reductions in total heterotopic ossification, or HO, lesion volume and no new HO lesions and flare activity in adolescents and adults with fibrodysplasia ossificans progressiva.The companies said the US Food and Drug Administration has accepted the new drug application and granted priority review for zilurgisertib as a treatment for fibrodysplasia ossificans progressiva in patients 12 years and older.The Prescription Drug User Fee Act target date for the product is Sept. 26, according to the companies.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","MIRM","BK4588","BK4139","BK4532","INCY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643333240","title":"Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study","url":"https://stock-news.laohu8.com/highlight/detail?id=2643333240","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643333240?lang=en_us&edition=fundamental","pubTime":"2026-06-15 05:20","pubTimestamp":1781472007,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals (MIRM) and Incyte (INCY) announced Phase 2 results from Cohort 1 of the Progress study evaluating zilurgisertib, an investiga...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-mirum-announces-phase-2-results-from-cohort-1-of-progress-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-mirum-announces-phase-2-results-from-cohort-1-of-progress-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4585","MIRM","INCY","BK4532","BK4139","BK4550","PRGS","BK4588","BK4097"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}